Trial Profile
Effects of addition of exenatide to metformin plus glibenclamide on beta cell and alpha cell function in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Glibenclamide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
- 08 Nov 2016 New trial record
- 16 Sep 2016 Results presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes